Clinical Trials ArenaOriginal article
Tortugas’ Phase IIb schizophrenia trial of obuprazine meets primary endpoint
Phase 2positiveobuprazinePositive
AI Analysis
Summary
Tortugas Neuroscience and partner Hansoh Pharma announced that their Phase IIb trial of obuprazine for acute schizophrenia met its primary endpoint.
Clinical Trial Data
Phase
Phase IIb
Primary Endpoint
Met
Outcome Details
Primary endpoint met in Phase IIb trial
Importance:7/10
Sentiment:
0.75
schizophreniaobuprazinePhase IIbclinical trialpositive result
Related Companies
Read the original article
Published by Clinical Trials Arena on October 13, 2026 8:02 AM